Scent of dying cells: The role of attraction signals in the clearance of apoptotic cells and its immunological consequences

Autoimmunity Reviews

Volumn 9, Issue 6, 2010, Pages 425-430

  Muñoz, Luis E ^a   Peter, Christoph ^b   Herrmann, Martin ^a   Wesselborg, Sebastian ^b   Lauber, Kirsten ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

'Find me' signals; Apoptosis; Attraction signals; Chemotaxis; Engulfment; Migration; Phagocytosis

Indexed keywords

CHEMOATTRACTANT; DIMER OF RIBOSOMAL PROTEIN S19; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; FRACTALKINE; INTERLEUKIN RECEPTOR; LACTOFERRIN; LYSOPHOSPHATIDYLCHOLINE; NUCLEOTIDE; PROTEIN; SOLUBLE INTERLEUKIN 6 RECEPTOR; SPHINGOSINE 1 PHOSPHATE; THROMBOSPONDIN 1; TYROSINE TRANSFER RNA LIGASE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL DEATH; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PHAGOCYTE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CHEMOKINES; CHEMOTAXIS; HUMANS; IMMUNITY; PARACRINE COMMUNICATION; PHAGOCYTES; PHAGOCYTOSIS;

EID: 77949914141     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.11.016     Document Type: Review

References (56)

1. Lauber K., Blumenthal S.G., Waibel M., and Wesselborg S. Clearance of apoptotic cells; getting rid of the corpses. Mol Cell 14 (2004) 277-287
2. Gaipl U.S., Munoz L.E., Grossmayer G., Lauber K., Franz S., Sarter K., Voll R.E., Winkler T., Kuhn A., Kalden J., et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 28 (2007) 114-121
3. Pisetsky D.S. The role of innate immunity in the induction of autoimmunity. Autoimmun Rev 8 (2008) 69-72
4. Lleo A., Selmi C., Invernizzi P., Podda M., and Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 31 (2008) 257-262
5. Krysko D.V., Denecker G., Festjens N., Gabriels S., Parthoens E., D'Herde K., and Vandenabeele P. Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells. Cell Death Differ 13 (2006) 2011-2022
6. Horino K., Nishiura H., Ohsako T., Shibuya Y., Hiraoka T., Kitamura N., and Yamamoto T. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest 78 (1998) 603-617
7. Nishimura T., Horino K., Nishiura H., Shibuya Y., Hiraoka T., Tanase S., and Yamamoto T. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J Biochem 129 (2001) 445-454
8. Yamamoto T. Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes. Pathol Int 57 (2007) 1-11
9. Schulze C., Munoz L.E., Franz S., Sarter K., Chaurio R.A., Gaipl U.S., and Herrmann M. Clearance deficiency-a potential link between infections and autoimmunity. Autoimmun Rev 8 (2008) 5-8
10. Knies U.E., Behrensdorf H.A., Mitchell C.A., Deutsch U., Risau W., Drexler H.C., and Clauss M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci U S A 95 (1998) 12322-12327
11. Kao J., Houck K., Fan Y., Haehnel I., Libutti S.K., Kayton M.L., Grikscheit T., Chabot J., Nowygrod R., Greenberg S., et al. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem 269 (1994) 25106-25119
12. Quevillon S., Agou F., Robinson J.C., and Mirande M. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J Biol Chem 272 (1997) 32573-32579
13. Behrensdorf H.A., van de Craen M., Knies U.E., Vandenabeele P., and Clauss M. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett 466 (2000) 143-147
14. Kao J., Fan Y.G., Haehnel I., Brett J., Greenberg S., Clauss M., Kayton M., Houck K., Kisiel W., Seljelid R., et al. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response. J Biol Chem 269 (1994) 9774-9782
15. Ko Y.G., Park H., Kim T., Lee J.W., Park S.G., Seol W., Kim J.E., Lee W.H., Kim S.H., Park J.E., et al. A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem 276 (2001) 23028-23033
16. Hou Y., Plett P.A., Ingram D.A., Rajashekhar G., Orschell C.M., Yoder M.C., March K.L., and Clauss M. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp Hematol 34 (2006) 1125-1132
17. Wakasugi K., and Schimmel P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284 (1999) 147-151
18. Mackay I.R., Leskovsek N.V., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
19. Krispin A., Bledi Y., Atallah M., Trahtemberg U., Verbovetski I., Nahari E., Zelig O., Linial M., and Mevorach D. Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood 108 (2006) 3580-3589
20. Adams J.C. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 17 (2001) 25-51
21. Savill J., Hogg N., Ren Y., and Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90 (1992) 1513-1522
22. Mansfield P.J., and Suchard S.J. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 153 (1994) 4219-4229
23. Lymn J.S., Patel M.K., Clunn G.F., Rao S.J., Gallagher K.L., and Hughes A.D. Thrombospondin-1 differentially induces chemotaxis and DNA synthesis of human venous smooth muscle cells at the receptor-binding level. J Cell Sci 115 (2002) 4353-4360
24. Chalaris A., Rabe B., Paliga K., Lange H., Laskay T., Fielding C.A., Jones S.A., Rose-John S., and Scheller J. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110 (2007) 1748-1755
25. Drucker C., Gewiese J., Malchow S., Scheller J., and Rose-John S. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. J Autoimmun (2009) S0896-8411(09)00102-4 [pii] 10.1016/j.jaut.2009.08.003
26. Rabe B., Chalaris A., May U., Waetzig G.H., Seegert D., Williams A.S., Jones S.A., Rose-John S., and Scheller J. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 111 (2008) 1021-1028
27. Truman L.A., Ford C.A., Pasikowska M., Pound J.D., Wilkinson S.J., Dumitriu I.E., Melville L., Melrose L.A., Ogden C.A., Nibbs R., et al. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112 (2008) 5026-5036
28. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9 (2006) 917-924
29. Miksa M., Amin D., Wu R., Ravikumar T.S., and Wang P. Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages. Mol Med 13 (2007) 553-560
30. Lauber K., Bohn E., Krober S.M., Xiao Y.J., Blumenthal S.G., Lindemann R.K., Marini P., Wiedig C., Zobywalski A., Baksh S., et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113 (2003) 717-730
31. Kim S.J., Gershov D., Ma X., Brot N., and Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196 (2002) 655-665
32. Peter C., Waibel M., Radu C.G., Yang L.V., Witte O.N., Schulze-Osthoff K., Wesselborg S., and Lauber K. Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A. J Biol Chem 283 (2008) 5296-5305
33. Munoz L.E., Gaipl U.S., Franz S., Sheriff A., Voll R.E., Kalden J.R., and Herrmann M. SLE-a disease of clearance deficiency?. Rheumatology (Oxford) 44 (2005) 1101-1107
34. Munoz L.E., Gaipl U.S., and Herrmann M. Predictive value of anti-dsDNA autoantibodies: importance of the assay. Autoimmun Rev 7 (2008) 594-597
35. Le L.Q., Kabarowski J.H., Weng Z., Satterthwaite A.B., Harvill E.T., Jensen E.R., Miller J.F., and Witte O.N. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14 (2001) 561-571
36. Murugesan G., Sandhya Rani M.R., Gerber C.E., Mukhopadhyay C., Ransohoff R.M., Chisolm G.M., and Kottke-Marchant K. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol 35 (2003) 1375-1384
37. Homma S., Yamamoto M., and Yamamoto N. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine. Immunol Cell Biol 71 Pt 4 (1993) 249-257
38. Yan J.J., Jung J.S., Lee J.E., Lee J., Huh S.O., Kim H.S., Jung K.C., Cho J.Y., Nam J.S., Suh H.W., et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 10 (2004) 161-167
39. Chen G., Li J., Qiang X., Czura C.J., Ochani M., Ochani K., Ulloa L., Yang H., Tracey K.J., Wang P., et al. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res 46 (2005) 623-627
40. Tincani A., Andreoli L., Bazzani C., Bosiso D., and Sozzani S. Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun Rev 7 (2007) 1-7
41. Gomez-Munoz A., O'Brien L., Hundal R., and Steinbrecher U.P. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. J Lipid Res 40 (1999) 988-993
42. Taniuchi M., Otani H., Kodama N., Tone Y., Sakagashira M., Yamada Y., Mune M., and Yukawa S. Lysophosphatidylcholine up-regulates IL-1 beta-induced iNOS expression in rat mesangial cells. Kidney Int Suppl 71 (1999) S156-S158
43. Coutant F., Perrin-Cocon L., Agaugue S., Delair T., Andre P., and Lotteau V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol 169 (2002) 1688-1695
44. Sakata-Kaneko S., Wakatsuki Y., Usui T., Matsunaga Y., Itoh T., Nishi E., Kume N., and Kita T. Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells. FEBS Lett 433 (1998) 161-165
45. Gude D.R., Alvarez S.E., Paugh S.W., Mitra P., Yu J., Griffiths R., Barbour S.E., Milstien S., and Spiegel S. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. Faseb J 22 (2008) 2629-2638
46. Weigert A., Tzieply N., von Knethen A., Johann A.M., Schmidt H., Geisslinger G., and Brune B. Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. Mol Biol Cell 18 (2007) 3810-3819
47. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5 (2005) 560-570
48. Segundo C., Medina F., Rodriguez C., Martinez-Palencia R., Leyva-Cobian F., and Brieva J.A. Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis. Blood 94 (1999) 1012-1020
49. Bournazou I., Pound J.D., Duffin R., Bournazos S., Melville L.A., Brown S.B., Rossi A.G., and Gregory C.D. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest 119 (2009) 20-32
50. Audrain M.A., Gourbil A., Muller J.Y., and Esnault L.M. Anti-lactoferrin autoantibodies: relation between epitopes and iron-binding domain. J Autoimmun 9 (1996) 569-574
51. Janko C., Schorn C., Grossmayer G.E., Frey B., Herrmann M., Gaipl U.S., and Munoz L.E. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev 8 (2008) 9-12
52. Haversen L., Ohlsson B.G., Hahn-Zoric M., Hanson L.A., and Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol 220 (2002) 83-95
53. Zimecki M., Artym J., Chodaczek G., Kocieba M., and Kruzel M. Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol Rep 57 (2005) 811-817
54. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., Park D., Woodson R.I., Ostankovich M., Sharma P., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461 (2009) 282-286
55. Idzko M., Hammad H., van Nimwegen M., Kool M., Willart M.A., Muskens F., Hoogsteden H.C., Luttmann W., Ferrari D., Di Virgilio F., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13 (2007) 913-919
56. Ghiringhelli F., Apetoh L., Tesniere A., Aymeric L., Ma Y., Ortiz C., Vermaelen K., Panaretakis T., Mignot G., Ullrich E., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15 (2009) 1170-1178